Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) EBT (2019 - 2025)

Historic EBT for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to -$50222.6.

  • Evotec SE's EBT rose 243.86% to -$50222.6 in Q3 2025 from the same period last year, while for Sep 2025 it was -$207.3 million, marking a year-over-year decrease of 13873.31%. This contributed to the annual value of -$207.3 million for FY2024, which is 13904.42% down from last year.
  • Latest data reveals that Evotec SE reported EBT of -$50222.6 as of Q3 2025, which was up 243.86% from -$207.1 million recorded in Q4 2024.
  • Over the past 5 years, Evotec SE's EBT peaked at $270.8 million during Q4 2021, and registered a low of -$207.1 million during Q4 2024.
  • Its 5-year average for EBT is -$11.3 million, with a median of -$24111.1 in 2023.
  • Its EBT has fluctuated over the past 5 years, first skyrocketed by 178431.71% in 2021, then tumbled by 40618.84% in 2024.
  • Evotec SE's EBT (Quarter) stood at $270.8 million in 2021, then tumbled by 158.05% to -$157.2 million in 2022, then surged by 44.88% to -$86.7 million in 2023, then plummeted by 138.99% to -$207.1 million in 2024, then skyrocketed by 99.98% to -$50222.6 in 2025.
  • Its last three reported values are -$50222.6 in Q3 2025, -$207.1 million for Q4 2024, and -$51477.9 during Q3 2024.